ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,559Medicare Part D Prescriptions Filled, Including Refills

Rank: 190 out of 944

$541K Total Retail Price of All Prescriptions

Rank: 172 out of 944

420 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,275 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 471 379 1 1
OMEPRAZOLE 377 299 2 4
LISINOPRIL 376 311 3 3
POLYETHYLENE GLYCOL 3350 282 126 4 41
LEVOTHYROXINE SODIUM 251 185 5 2
AMLODIPINE BESYLATE 234 210 6 5
METOPROLOL TARTRATE 223 200 7 8
HYDROCODONE-ACETAMINOPHEN 212 147 S3 8 10
FUROSEMIDE 172 154 9 6
METOPROLOL SUCCINATE 162 119 10 14
METFORMIN HCL 161 106 11 12
MIRTAZAPINE 153 124 12 35
ATENOLOL 151 131 13 11
TRAMADOL HCL 140 114 14 21
CITALOPRAM HBR 137 95 15 19
SERTRALINE HCL 135 128 16 23
WARFARIN SODIUM 124 105 17 7
POTASSIUM CHLORIDE 118 81 18 15
OXYBUTYNIN CHLORIDE 113 83 19 94
RANITIDINE HCL 107 72 20 42
LOSARTAN POTASSIUM 95 82 21 16
LANTUS 94 57 22 46
ALENDRONATE SODIUM 92 80 23 20
LIDODERM 91 87 24 73
HYDROCHLOROTHIAZIDE 90 75 25 9
NOVOLOG 90 75 25 93
GABAPENTIN 86 53 27 18
GLIMEPIRIDE 82 57 28 47
RISPERIDONE 81 27 29 78
PLAVIX 78 72 30 55
CARBIDOPA-LEVODOPA 69 54 31 77
SEROQUEL 67 62 32 142
FLUTICASONE PROPIONATE 66 57 33 40
DIVALPROEX SODIUM 66 18 33 85
ADVAIR DISKUS 64 38 35 31
ISOSORBIDE MONONITRATE ER 63 53 36 52
TRAZODONE HCL 62 52 37 45
PRAVASTATIN SODIUM 62 46 37 17
VENTOLIN HFA 61 45 39 116
SPIRONOLACTONE 60 44 40 44
FENTANYL 59 58 S2 41 57
ZETIA 56 43 42 59
PANTOPRAZOLE SODIUM 55 19 43 34
DOXAZOSIN MESYLATE 55 53 43 60
FLUOXETINE HCL 53 35 45 48
DIOVAN 50 50 46 38
TRANSDERM-SCOP 50 50 46 262
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.